SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

The Dogecoin community is abuzz with speculation over its potential integration into Elon Musk's X platform for payments, driving fervent hopes for a significant rally while others caution against market volatility.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is experiencing strong upward momentum, with the crypto community enthusiastically discussing a "meme coin season" and its potential for significant gains, often framing it as the "alpha frog" in a broader "three frog narrative."

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amidst widespread community discussion of a potential 'meme coin season,' with many comparing its performance to other surging meme tokens like PEPE and DOGE while a significant portion of the community expresses frustration and skepticism regarding its long-term viability.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as the FDA granted Priority Review for AXS-05 to treat Alzheimer's disease agitation, with an April PDUFA date, fueling community optimism alongside robust sales growth for its major depressive disorder treatment, Auvelity. Investors are keenly discussing the significant market potential for its expanding neuroscience pipeline and the company's strong commercial execution, with many anticipating substantial share appreciation.

Ramaco Resources, Inc. engages in the operation and development of coal mining properties. The firm deals with metallurgical coal in central and southern West Virginia, southwestern Virginia and southwestern Pennsylvania. Its portfolio consists of Elk Creek, Berwind, RAM Mine, and Knox Creek. The company was founded by Randall W. Atkins in August 2015 and is headquartered in Lexington, KY.

Ramaco Resources Inc - Ordinary Shares - Class A

Ramaco Resources Inc

Ramaco Resources is trending due to high anticipation for the upcoming Critical Minerals Summit, with the community actively discussing potential U.S. government investment in domestic critical mineral producers and the company's unique position with its Brook Mine rare earth project, further boosted by a recent analyst upgrade despite past volatility over potential price floor policies.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as its preliminary financial results highlight strong initial sales for Tonmya, prompting community discussion about the new fibromyalgia treatment's promising launch trajectory compared to other CNS drugs. Despite historical concerns regarding dilution, increasing institutional ownership and the company's significant cash reserves are driving a narrative that the stock is currently undervalued given Tonmya's commercial traction and pipeline potential.

Seeker is building a decentralized mobile ecosystem designed to challenge entrenched mobile incumbents through its TEEPin network architecture and community governance. It aims to solve the pain points of centralized app store gatekeeping, lack of developer freedom, and restricted user access to crypto applications. The vision is to create a community-owned platform with decentralized governance, no gatekeepers, direct developer-user access, and TEEPin security architecture.

Saakuru

Despite confusion around its ticker identity on some platforms, the crypto community is actively discussing a token, widely believed to be the "Seeker Solana Smartphone Token," following its new listings on major exchanges and recent airdrops to Solana phone owners. This asset is experiencing significant momentum, drawing comparisons to past Solana ecosystem pumps, while some caution about potential profit-taking and volatility.

BlockDAG

BlockDAG is trending as its community grapples with continuous, often conflicting, announcements regarding its mainnet launch and exchange listings, leading to widespread speculation and frustration over perceived delays, lost coins, and concerns about the project's overall legitimacy as a presale.

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.

Upstream Bio Inc.

Upstream Bio is trending due to a significant market sell-off following its Phase 2 VALIANT trial results for verekitug in severe asthma. Although the drug showed strong efficacy with quarterly dosing, the community is debating an 'overreaction' because the highly anticipated biannual dosing did not meet market expectations, with many investors now viewing it as a dip-buying opportunity.

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company continuously increases its depth of capabilities across its broad portfolio of innovative products and services and leverages its extensive global channels to address customers’ needs. The company does this through organic investments in research and development, capacity and capabilities and through acquisitions. The company’s goal is to enable its customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work. The company’s history roots back to the year 1956 when the business was first established. Thermo Fisher Scientific was formed in 2006 from the merger of Thermo Electron and Fisher Scientific and is headquartered in Waltham, MA.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is at the center of investor discussion following multiple strong earnings beats and strategic collaborations, notably with NVIDIA for AI-driven lab automation, pointing to robust future growth in the life sciences sector. Despite recent "brutal downward movement" in its stock price, the community is weighing these positive catalysts and numerous analyst upgrades against broader market softness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>According to a report from CNBC that cited people close to the company, the deal is worth over $10 billion.&nbsp;</li><li>Cerebras said that the partnership was a decade in the making, with teams of both companies having met frequently since 2017 to share research and other work.&nbsp;</li><li>Cerebras is an artificial intelligence company that builds Wafer-Scale Engines (WSEs) designed to train and run generative AI models that are touted to respond up to 15 times faster than GPU-based systems.</li></ul>ChatGPT’s OpenAI and AI chipmaker Cerebras Systems on Wednesday announced that they have signed a 750 megawatts multi-year computing power agreement.Both companies announced the plans on their websites. The deployment will roll out in multiple stages starting in 2026 and make it the largest high-speed AI inference deployment in the world, Cerebras said.Meanwhile, OpenAI said in its statement that capacity will go online in multiple tranches through 2028.<h2 class="st-heading-2">Deal Contours</h2>According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2026/01/14/cerebras-scores-openai-deal-worth-over-10-billion.html">report</a> from CNBC that cited people close to the company, the deal is worth over $10 billion.Cerebras said that the partnership was a decade in the making, with teams having met frequently since 2017 to share research. Under the deal, Cerebras will deploy its wafer-scale systems to serve OpenAI customers.“For Cerebras, 2026 is shaping up to be an extraordinary year. In collaborating with OpenAI, the wafer-scale technology we pioneered will reach hundreds of millions—and eventually billions—of users,” the company said.“OpenAI’s compute strategy is to build a resilient portfolio that matches the right systems to the right workloads. Cerebras adds a dedicated low-latency inference solution to our platform. That means faster responses, more natural interactions, and a stronger foundation to scale real-time AI to many more people,” said Sachin Katti, who works with OpenAI’s compute infrastructure.<h2 class="st-heading-2">What Is Cerebras?</h2>Cerebras is an artificial intelligence company that positions itself as a high-speed solution for AI. The company builds Wafer-Scale Engines (WSEs) or large processors designed to train and run generative AI models touted to provide responses up to 15 times faster than GPU-based systems.This makes Cerebras a competitor to companies like Nvidia Corp. (NVDA), which provides GPU-based solutions and is the largest semiconductor company in the world.Earlier, Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-01-13/cerebras-in-discussions-to-raise-funds-at-22-billion-valuation">reported,</a> citing a person familiar with the matter, that Cerebras was in talks to raise about $1 billion in a new funding round, valuing it at $22 billion before the investment. The company was still planning to pursue an initial public offering, as per the report.Cerebras <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/2021728/000162828024041596/cerebras-sx1.htm">filed</a> for an IPO with the U.S. Securities and Exchange Commission in 2024, without a set share price or expected market cap. The company was expected to go public in 2025, but <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/2021728/000119312525230382/d886849drw.htm">withdrew</a> its plans in October 2025.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around OpenAI was in the ‘neutral’ territory amid ‘high’ message volumes.Meanwhile, retail sentiment around Cerebras Systems was in the ‘neutral’ territory amid ‘normal’ message volumes.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration the logo of OpenAI Voice Engine is seen on the mobile phone. (Photo by Dilara Irem Sancar/Anadolu via Getty Images)

OpenAI Partners With Cerebras For 750 MW Computing Power Deal Through 2028

The deployment will roll out in multiple stages starting in 2026 and make it the largest high-speed AI inference deployment in the world, Cerebras said.

Equity

<ul class="summary-bullets"><li>Gavin Baker said Nvidia’s Groq licensing deal raises competitive pressure on standalone AI ASIC developers.</li><li>Baker said inference is splitting into prefill and decode, with Nvidia using Rubin CPX, Rubin, and a Groq-derived SRAM variant for different workloads.</li><li>Baker said customers are now willing to pay for SRAM speed, increasing his confidence that most AI ASICs will be canceled except TPU, AI5, and Trainium.</li></ul>Gavin Baker, managing partner at Atreides Management, said Nvidia’s decision to license technology from AI startup Groq points to mounting pressure on independent artificial intelligence (AI) chip firms and reinforces his view that the sector is moving toward consolidation.The stock rose 1.2% to $190.89 at the time of writing.<h2 class="st-heading-2">Baker Flags Competitive Pressure&nbsp;</h2>Baker said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/GavinSBaker/status/2004562536918598000">post on X</a> that Nvidia’s approach of combining multiple architectures raises the competitive bar for standalone AI application-specific integrated circuit (ASIC) developers.The comments came after Nvidia disclosed a licensing arrangement with Groq. Nvidia said it has agreed to a licensing deal that gives it the right to integrate Groq’s chip design into future products, while Groq will continue operating as an independent company. Some of Groq’s senior executives will join Nvidia to help scale the licensed technology. Financial terms were not disclosed.<h2 class="st-heading-2">Baker Details Prefill And Decode Workloads</h2>Baker said inference workloads are increasingly disaggregating into prefill and decode stages, with each phase favoring different hardware characteristics. He said prefill workloads reward memory capacity, while decode workloads depend on extremely high memory bandwidth and low latency.He said Nvidia’s Rubin CPX, Rubin, and a Groq-derived static random-access memory (SRAM) variant can be used together, with Rubin CPX optimized for massive context windows during prefill, Rubin used for training and high-density, batched inference workloads, and the Groq-derived variant optimized for ultra-low-latency, agentic reasoning inference workloads.<h2 class="st-heading-2">SRAM Performance Gains Are Now Clear</h2>Baker said SRAM-based architectures can deliver token-per-second performance far exceeding graphics processing units (GPUs), tensor processing units (TPUs), or other ASICs, even though they come at a higher cost per token due to smaller batch sizes. He said recent results from Groq and Cerebras show customers are willing to pay for speed and low latency, resolving a key uncertainty from roughly 18 months ago.Based on that shift, Baker said his confidence has increased that all application-specific integrated circuits will eventually be canceled except TPU, AI5, and Trainium.Baker said Groq’s many-chip rack architecture was much easier to integrate with Nvidia’s networking stack and potentially within a single rack, while Cerebras’s wafer-scale engine almost requires an independent rack.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for Nvidia was ‘bearish’ amid ‘low’ message volume.<figure class="image"><img style="aspect-ratio:975/144;" src="https://news.stocktwits-cdn.com/nvda_ss_png_e23bb768ea.webp" alt="nvda ss.png" width="975" height="144"><figcaption>NVDA sentiment and message volume as of December 26| Source: Stocktwits</figcaption></figure>One user expects the stock to “go to all time high” before the end of the year.<stembedurl>https://stocktwits.com/AqAQ/message/640169940</stembedurl>Another user said, “they [Nvidia] were already laps ahead of their competition. This deal not only secured that lead but extended it. Perfect synergy with Groq”<stembedurl>https://stocktwits.com/Jagr99/message/640169464</stembedurl><a href="https://stocktwits.com/symbol/NVDA">Nvidia’s stock</a> has risen 42% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Nvidia is displayed on a smartphone screen on November 24, 2025 in Chongqing, China.

Why Gavin Baker Thinks Nvidia’s Groq Deal Is Bad News For Many AI Chip Firms

Nvidia’s Groq deal underscores a narrowing field for independent AI chipmakers, according to Gavin Baker.

Palo Alto Networks, Inc. (PANW) stock traded 4.8% lower on Wednesday as several analysts slashed the firm’s price target following the&nbsp;company’s&nbsp;third-quarter earnings.Palo Alto reported&nbsp;third quarter (Q3) revenue of $2.29 billion, beating estimates of $2.28 billion, and adjusted earnings per share of $0.80, beating estimates of $0.77, as per Finchat data.Bernstein analyst Peter Weed reduced the price target for Palo Alto to $225 from $229 while maintaining an ‘Outperform’ rating on the stock,&nbsp;as per TheFly.According to the analyst, the company showed a modest 0.7% outperformance relative to the midpoint for Q3 next-generation security annual recurring revenue (NGS ARR), which has drawn significant investor attention.Palo Alto Networks projected its strongest sequential NGS ARR growth since launching its platformization initiative, said the analyst.JPMorgan revised its price target, cutting it to $221 from $225 while reiterating an ‘Overweight’ rating.&nbsp;In a note to investors&nbsp;cited by TheFly, the firm stated that although the company posted solid operating margins and met growth expectations, these positives were tempered by weaker-than-anticipated gains in net new annual recurring revenue and remaining performance obligations.&nbsp;Despite these challenges, the note points to encouraging signs that agentic AI is shifting from experimental stages to real-world implementation.&nbsp;The firm also noted Palo Alto’s proactive stance in AI-related cybersecurity, positioning itself as a frontrunner among platform providers preparing for widespread AI integration.Barclays slashed its price target on Palo Alto to $210 from $213 while maintaining an ‘Overweight’ rating.&nbsp;The firm noted that fiscal Q3 results were generally in line with expectations, showing stronger annual recurring revenue, though bookings for remaining performance obligations came in slightly below estimates due to a more challenging April.&nbsp;Barclays expressed increased confidence in the company’s ARR growth trajectory for Q4 and fiscal 2026&nbsp;(FY26)&nbsp;but opted to modestly lower its FY26 revenue growth estimate to 13% as a precaution.Northland cut the price target on the stock to $177 from $210 while maintaining a Market Perform rating.&nbsp;The brokerage&nbsp;scaled back&nbsp;its&nbsp;long-term growth outlook and no longer sees justification for forecasting growth to accelerate beyond the 17%&nbsp;to&nbsp;19% range the company suggested early in its platformization strategy.On Stocktwits, retail sentiment around Palo Alto remained&nbsp;in&nbsp;‘extremely bullish’&nbsp;territory.<figure class="image"><img style="aspect-ratio:630/76;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_21_133217_png_abf377b052.webp" alt="PANW's Sentiment Meter and Message Volume as of 01:40 p.m. ET on May 21, 2025 | Source: Stocktwits" width="630" height="76"><figcaption>PANW's Sentiment Meter and Message Volume as of 01:40 p.m. ET on May 21, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user hoped for a stock rebound.<stembedurl>https://stocktwits.com/TheBullishTrade/message/615374173</stembedurl><a href="https://stocktwits.com/symbol/PANW">Palo Alto</a> stock added 0.7% year-to-date and 17.6% in the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/leddartech-announces-workforce-reduction/ch0e4KhRbY1">LeddarTech Stock Gets Battered After Slashing 95% Workforce: Retail Bearish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Palo Alto Networks logo is displayed on a smartphone screen on February 10, 2025, in Chongqing, China. 

Palo Alto Slides As Analysts Slash Price Targets Post Q3 Print, But Retail Is Buoyant 

Analysts trimmed price targets due to softer recurring revenue growth and cautious longer-term outlooks amid evolving AI strategies.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

CBRS
Cerebras Systems

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest CBRS News

CBRSCerebras Systems